Rani Therapeutics Holdings Stock Probability of Future Stock Price Finishing Over 2.2
| RANI Stock | USD 1.47 0.03 2.00% |
Rani |
Rani Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Rani Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Rani Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Rani Therapeutics had very high historical volatility over the last 90 days | |
| Rani Therapeutics may become a speculative penny stock | |
| Rani Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (33.97 M) with profit before overhead, payroll, taxes, and interest of 2.72 M. | |
| Rani Therapeutics Holdings currently holds about 98.17 M in cash with (51.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.97, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Rani Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company outstanding shares are owned by corporate insiders |
Rani Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Rani Stock often depends not only on the future outlook of the current and potential Rani Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rani Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 25.5 M | |
| Cash And Short Term Investments | 48.5 M |
Rani Therapeutics Technical Analysis
Rani Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Rani Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Rani Therapeutics Holdings. In general, you should focus on analyzing Rani Stock price patterns and their correlations with different microeconomic environments and drivers.
Rani Therapeutics Predictive Forecast Models
Rani Therapeutics' time-series forecasting models is one of many Rani Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Rani Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Rani Therapeutics
Checking the ongoing alerts about Rani Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Rani Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Rani Therapeutics had very high historical volatility over the last 90 days | |
| Rani Therapeutics may become a speculative penny stock | |
| Rani Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (33.97 M) with profit before overhead, payroll, taxes, and interest of 2.72 M. | |
| Rani Therapeutics Holdings currently holds about 98.17 M in cash with (51.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.97, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Rani Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company outstanding shares are owned by corporate insiders |
Check out Rani Therapeutics Backtesting, Rani Therapeutics Valuation, Rani Therapeutics Correlation, Rani Therapeutics Hype Analysis, Rani Therapeutics Volatility, Rani Therapeutics History as well as Rani Therapeutics Performance. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rani Therapeutics. If investors know Rani will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rani Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Rani Therapeutics is measured differently than its book value, which is the value of Rani that is recorded on the company's balance sheet. Investors also form their own opinion of Rani Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Rani Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rani Therapeutics' market value can be influenced by many factors that don't directly affect Rani Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rani Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rani Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rani Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.